These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


183 related items for PubMed ID: 12971434

  • 1. The impact of MELD on OPTN liver allocation: preliminary results.
    Edwards EB, Harper AM.
    Clin Transpl; 2002; ():21-8. PubMed ID: 12971434
    [Abstract] [Full Text] [Related]

  • 2. The impact of PELD on OPTN liver allocation: preliminary results.
    Davies DB.
    Clin Transpl; 2003; ():13-20. PubMed ID: 15387095
    [Abstract] [Full Text] [Related]

  • 3. Application of a continuous disease severity score to the OPTN liver waiting list.
    Edwards EB, Harper AM.
    Clin Transpl; 2001; ():19-24. PubMed ID: 12211782
    [Abstract] [Full Text] [Related]

  • 4. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
    Tenório AL, Macedo FI, Miranda LE, Fernandes JL, da Silva CM, Neto OL, Lacerda CM.
    Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152
    [Abstract] [Full Text] [Related]

  • 5. Model for end-stage liver disease: impact of the new deceased donor liver allocation policy in São Paulo, Brazil.
    Monteiro F, Coria SA, Boni R, Pereira LA.
    Transplant Proc; 2009 Mar; 41(1):226-8. PubMed ID: 19249520
    [Abstract] [Full Text] [Related]

  • 6. Prolonged waiting times for liver transplantation in obese patients.
    Segev DL, Thompson RE, Locke JE, Simpkins CE, Thuluvath PJ, Montgomery RA, Maley WR.
    Ann Surg; 2008 Nov; 248(5):863-70. PubMed ID: 18948816
    [Abstract] [Full Text] [Related]

  • 7. Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?
    Silberhumer GR, Hetz H, Rasoul-Rockenschaub S, Peck-Radosavljevic M, Soliman T, Steininger R, Muehlbacher F, Berlakovich GA.
    Transpl Int; 2006 Apr; 19(4):275-81. PubMed ID: 16573542
    [Abstract] [Full Text] [Related]

  • 8. Overview of the MELD score and the UNOS adult liver allocation system.
    Martin AP, Bartels M, Hauss J, Fangmann J.
    Transplant Proc; 2007 Dec; 39(10):3169-74. PubMed ID: 18089345
    [Abstract] [Full Text] [Related]

  • 9. Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality.
    Ben-Haim M, Carmiel M, Katz P, Shabtai E, Oren R, Nakache R.
    Isr Med Assoc J; 2006 Sep; 8(9):605-9. PubMed ID: 17058408
    [Abstract] [Full Text] [Related]

  • 10. Results of the first year of the new liver allocation plan.
    Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R, United Network for Organ Sharing Organ Procurement and Transplantation Network Liver and Transplantation Committee.
    Liver Transpl; 2004 Jan; 10(1):7-15. PubMed ID: 14755772
    [Abstract] [Full Text] [Related]

  • 11. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
    Santori G, Andorno E, Morelli N, Casaccia M, Bottino G, Ghirelli R, Valente U.
    Transplant Proc; 2008 Jan; 40(6):1903-5. PubMed ID: 18675084
    [Abstract] [Full Text] [Related]

  • 12. ABO blood group-related waiting list disparities in liver transplant candidates: effect of the MELD adoption.
    Barone M, Avolio AW, Di Leo A, Burra P, Francavilla A.
    Transplantation; 2008 Mar 27; 85(6):844-9. PubMed ID: 18360266
    [Abstract] [Full Text] [Related]

  • 13. Is MELD really the definitive score for liver allocation?
    Lladó L, Figueras J, Memba R, Xiol X, Baliellas C, Vázquez S, Ramos E, Torras J, Rafecas A, Fabregat J, Lama C, Jaurrieta E.
    Liver Transpl; 2002 Sep 27; 8(9):795-8. PubMed ID: 12200780
    [Abstract] [Full Text] [Related]

  • 14. Model for End-Stage Liver Disease (MELD) system to allocate and to share livers: experience of two Italian centers.
    Ravaioli M, Masetti M, Dazzi A, Romano A, Spaggiari M, Grazi GL, Ercolani G, Cescon M, Di Gioia P, De Ruvo N, Montalti R, Ballarin R, Di Benedetto F, Ridolfi L, Alvaro N, Ramacciato G, Morelli C, Gerunda E, Pinna AD.
    Transplant Proc; 2008 Sep 27; 40(6):1814-5. PubMed ID: 18675057
    [Abstract] [Full Text] [Related]

  • 15. National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003-2004).
    Shneider BL, Suchy FJ, Emre S.
    Liver Transpl; 2006 Jan 27; 12(1):40-5. PubMed ID: 16382460
    [Abstract] [Full Text] [Related]

  • 16. Liver transplantation for hepatocellular carcinoma: the MELD impact.
    Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, Byrne T, Vargas HE, Mulligan D, Rakela J, Wiesner RH.
    Liver Transpl; 2004 Jan 27; 10(1):36-41. PubMed ID: 14755775
    [Abstract] [Full Text] [Related]

  • 17. Selection of pediatric candidates under the PELD system.
    McDiarmid SV, Merion RM, Dykstra DM, Harper AM.
    Liver Transpl; 2004 Oct 27; 10(10 Suppl 2):S23-30. PubMed ID: 15384170
    [Abstract] [Full Text] [Related]

  • 18. Risk factors for liver transplantation waiting list mortality.
    Fink MA, Berry SR, Gow PJ, Angus PW, Wang BZ, Muralidharan V, Christophi C, Jones RM.
    J Gastroenterol Hepatol; 2007 Jan 27; 22(1):119-24. PubMed ID: 17201891
    [Abstract] [Full Text] [Related]

  • 19. Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans.
    Ahmad J, Downey KK, Akoad M, Cacciarelli TV.
    Liver Transpl; 2007 Nov 27; 13(11):1564-9. PubMed ID: 17969210
    [Abstract] [Full Text] [Related]

  • 20. Excellent liver transplant survival rates under the MELD/PELD system.
    Freeman RB, Harper A, Edwards EB.
    Transplant Proc; 2005 Mar 27; 37(2):585-8. PubMed ID: 15848465
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.